This ruling keeps Kroger's antitrust claims alive but is early-stage procedural. Monitor for summary judgment motions and potential settlement developments in the MDL. The case remains in discovery phase—no immediate financial impact on Kroger.
Price Chart
Executive Summary
In the Generic Pharmaceuticals MDL 2724 antitrust litigation, the court denied Epic Pharma's motions to dismiss claims against it in eight of eleven complaints, including the one filed by The Kroger Co. The Kroger complaint survived because it sufficiently alleged Epic conspired with Lannett and Actavis to fix prices of Ursodiol, including a 1000% price increase by Epic. This ruling keeps Kroger's antitrust claims alive, preserving the potential for damages recovery, but is an interlocutory procedural ruling—not a final judgment—so no damages have been awarded.
Court Ruling Details
Key Facts
- Kroger is one of 11 plaintiffs in the Generic Pharmaceuticals MDL 2724 antitrust litigation against Epic Pharma.
- The court denied Epic's motion to dismiss Kroger's complaint, allowing the case to proceed.
- Kroger's complaint alleges Epic conspired with Lannett and Actavis to raise Ursodiol prices, including a 1000% price increase by Epic.
- Three other complaints (HCSC, Molina, CVS) were dismissed for failing to adequately plead Epic's involvement.
- This is a motion-to-dismiss ruling under Rule 12(b)(6), not a final judgment on the merits.
- No damages have been awarded; the ruling only determines the complaint states a plausible claim.
Financial Impact
No damages awarded or quantified in the ruling. Potential exposure for Epic is not stated.
Risk Factors
- Kroger must still prove its allegations at trial or through summary judgment.
- Appeals or further motions could still result in dismissal.
- The MDL has been ongoing for nearly a decade—resolution timeline is uncertain.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-lvpf066w-KR |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | 8-K | $58.49 $60.00 | ▲ +2.58% | ▲ +2.80% | $59.37 (+1.50%) |
Sep 2, 2026 29d ago | 8-K | $58.51 $58.49 | ▼ −0.03% | ▲ +1.11% | $59.37 (+1.47%) |
Jul 1, 2026 13w ago | 8-K | $56.24 $58.54 | ▲ +4.09% | ▲ +3.83% | $59.37 (+5.57%) |
Jun 26, 2026 13w ago | 8-K | $55.91 $58.25 | ▲ +4.19% | ▲ +2.80% | $59.37 (+6.19%) |
Jun 25, 2026 14w ago | Court Ruling | $57.77 $58.22 | ▲ +0.78% | ▼ −0.65% | $59.37 (+2.77%) |
Jun 18, 2026 15w ago | 8-K | $56.61 $57.77 | ▲ +2.05% | ▲ +3.71% | $59.37 (+4.88%) |
May 27, 2026 18w ago | 8-K | $64.69 $61.22 | ▼ −5.37% | ▼ −5.84% | $59.37 (−8.22%) |
May 19, 2026 19w ago | Court Ruling | $70.62 $64.85 | ▲ +8.17% | ▲ +10.41% | $59.37 (+15.93%) |
May 12, 2026 20w ago | Court Ruling | $64.62 $70.60 | ▲ +9.25% | ▲ +9.86% | $59.37 (−8.12%) |
Apr 29, 2026 22w ago | Court Ruling | $67.09 $66.92 | ▼ −0.25% | ▼ −3.36% | $59.37 (−11.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access